-
941por Podell, Rachel, Shriqui, Vered Kaufman, Sagy, Yael Wolff, Manor, Orly, Ben-Yehuda, Arie“…RESULTS: During the measurement period, vaccination rates significantly increased (Influenza: from 42.0% in 2002 to 63.2% in 2015; and pneumococcal vaccination: from 25.8% in 2005 to 77.0% in 2015). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
942por Essink, Brandon, Sabharwal, Charu, Xu, Xia, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Pride, Michael W, Scully, Ingrid L, Jansen, Kathrin U, Gruber, William C, Scott, Daniel, Watson, Wendy“…METHODS: Adults naïve to pneumococcal vaccination were enrolled into 3 age cohorts (≥60, 50–59, and 18–49 years of age). …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
943por Butler, Madeleine E. B., Jansen van Rensburg, Melissa J., Karani, Angela, Mvera, Benedict, Akech, Donald, Akter, Asma, Forrest, Calum, van Tonder, Andries J., Quirk, Sigríður J., Haraldsson, Gunnsteinn, Bentley, Stephen D., Erlendsdóttir, Helga, Haraldsson, Ásgeir, Kristinsson, Karl G., Scott, J. Anthony G., Brueggemann, Angela B.“…Here, the distribution of bacteriocins was examined in over 5000 carriage and disease-causing pneumococci from Iceland and Kenya, recovered before and after the introduction of pneumococcal vaccination. Overall, up to eleven different bacteriocin gene clusters were identified per pneumococcus. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
944por Giannattasio, Antonietta, Squeglia, Veronica, Lo Vecchio, Andrea, Russo, Maria Teresa, Barbarino, Alessandro, Carlomagno, Raffaella, Guarino, Alfredo“…RESULTS: Less than 25% of children in each group received pneumococcal vaccination. Vaccination rates against influenza were 73% in patients with HIV-infection, 90% in patients with cystic fibrosis, 76% in patients with liver transplantation, and ranged from 21% to 61% in patients with diabetes mellitus. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
945por Pido-Lopez, Jeffrey, Kwok, William W., Mitchell, Timothy J., Heyderman, Robert S., Williams, Neil A.“…However, if dysregulated, such responses may render the host more susceptible to invasive pneumococcal infection and adversely affect the successful implementation of both polysaccharide-conjugate and novel protein-based pneumococcal vaccines.…”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
946“…The logistic regression model contains nine predictors: age, pneumococcal vaccination, time since last checkup, highest education level attained, employment, health care coverage, number of personal doctors, smoker status, and annual household income. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
947por Scelfo, Chiara, Menzella, Francesco, Fontana, Matteo, Ghidoni, Giulia, Galeone, Carla, Facciolongo, Nicola Cosimo“…In order to reduce morbidity and mortality caused by this agent, pneumococcal vaccines have been developed over the years and have shown incredible effectiveness in reducing the spread of this bacterium and the development of related diseases, obtaining a significant reduction in mortality, especially in developing countries. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
948“…Influenza and pneumococcal vaccination is recommended. Treatment of hypoxaemia and hypercapnia reduce the rate of COPD exacerbations, while most interventional bronchoscopic therapies increase exacerbation risk within the first months after the procedure.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
949por Xue, Shuyue, Rogers, Lavida R.K., Zheng, Minzhang, He, Jin, Piermarocchi, Carlo, Mias, George I.“…We focus on expression changes: (i) in saliva of a human subject after pneumococcal vaccination (PPSV23) and (ii) in primary B cells treated ex vivo with a monoclonal antibody drug (Rituximab). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
950“…Furthermore, determination of hepatitis B antibody titers could be useful in newly diagnosed CD subjects regardless of age at diagnosis. Finally, pneumococcal vaccines may be administered in patients with advancing age at diagnosis and concomitant risk factors. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
951por Törő, Klára, Vörös, Krisztina, Mészner, Zsófia, Váradi-T, Aletta, Tóth, Adrienn, Kovács, Katalin“…In this study, we compared the incidence of explained and unexplained infant deaths in Hungary for three periods: 1979–1989 when the incidence of SIDS was high in western Europe; 1990–1999 when the incidence of infant deaths was falling following introduction of the public health campaigns to reduce the risk factors associated with SIDS; and 2000–2012 to determine if introduction of Haemophilus influenzae type b or pneumococcal vaccines or introduction of an earlier immunization schedule during this period had an effect on SIDS. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
952por Dixit, Cheshil, Keller, Lance E., Bradshaw, Jessica L., Robinson, D. Ashley, Swiatlo, Edwin, McDaniel, Larry S.“…NESp are a growing concern as an emerging human pathogen, as current pneumococcal vaccines do not confer immunity against them. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
953por van Kessel, Diana, Hoffman, Thijs, van Velzen-Blad, Heleen, Meek, Bob, van Mens, Suzan, Grutters, Jan, Rijkers, Ger“…It is unknown whether these patients are unable to produce an adequate anti-polysaccharide antibody response to pneumococcal vaccination after recovery. CASE PRESENTATION: The authors describe a case of invasive pneumonia caused by Streptococcus pneumoniae serotype 9V in a previously healthy 35-year-old female. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
954“…Partners such as the Global Alliance for Vaccines and Immunisation (GAVI), the Hib Initiative, the Accelerated Development and Introduction Plan for pneumococcal vaccines and the Measles Initiative, have accelerated the introduction of vaccines into developing countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
955por Murdaca, Giuseppe, Noberasco, Giovanni, Olobardi, Dario, Ogliastro, Matilde, Sibilio, Raffaella, Sambuceti, Giacomo, Balzano, Riccardo, Sticchi, Laura, Icardi, Giancarlo, Orsi, Andrea“…The patients followed up in this study reached higher percentages than the general population, passing the 75% target for both influenza and anti-pneumococcal vaccinations and reaching for influenza vaccine coverage rates of 83.8% for subjects undergoing immunosuppressive therapies and 88.9% for elderly subjects. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
956“…With a goal of leaving no one behind, India’s UIP and partners are bringing essential rotavirus and pneumococcal vaccines nationwide, upgrading vaccine cold chain and supply systems with technologies, such as the electronic Vaccine Intelligence Network (eVIN), and optimizing funding for local needs through the Program Implementation Plan (PIP) budgetary processes and building health worker capacities through training, awareness, and e-learning.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
957“…Although multi-valent pneumococcal vaccines have curbed the incidence of disease, their introduction has resulted in shifted serotype distributions that must be monitored. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
958por Williams, Charles Travers, Zaidi, Syed Tabish Razi, Saini, Bandana, Castelino, Ronald“…Influenza and pneumococcal vaccines had the most evidence for inclusion. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
959por Sempere, Julio, Llamosí, Mirella, del Río Menéndez, Idoia, López Ruiz, Beatriz, Domenech, Mirian, González-Camacho, Fernando“…Therefore, there is an urgent need to develop new pneumococcal vaccines which could cover a wide range of serotypes. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
960“…BACKGROUND: Earlier cost-effectiveness studies showed the cost-effectiveness ratios for pneumococcal vaccination in preventing cases of Bacteremic Pneumococcal Disease (BPD) alone to vary between € 11,000 and € 33,000 per quality-adjusted life year. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto